LabGenomics Co., Ltd. (KOSDAQ:084650)
South Korea flag South Korea · Delayed Price · Currency is KRW
742.00
-14.00 (-1.85%)
Jun 30, 2026, 9:50 AM KST

LabGenomics Revenue

LabGenomics had revenue of 17.93B KRW in the quarter ending March 31, 2026, a decrease of -18.13%. This brings the company's revenue in the last twelve months to 84.19B, down -4.22% year-over-year. In the year 2025, LabGenomics had annual revenue of 88.16B with 2.63% growth.

Revenue (ttm)
84.19B
Revenue Growth
-4.22%
P/S Ratio
0.67
Revenue / Employee
801.81M
Employees
105
Market Cap
56.13B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202588.16B2.26B2.63%
Dec 31, 202485.90B14.82B20.85%
Dec 31, 202371.08B-73.70B-50.90%
Dec 31, 2022144.77B-57.63B-28.47%
Dec 31, 2021202.41B82.93B69.41%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
DRTECH122.78B
Osang Healthcare Co.,Ltd119.38B
Ray Co., Ltd.112.53B
Humasis32.87B
T&R Biofab29.73B
HASS Corp.16.58B
Access Bio14.94B
Sugentech9.87B
Revenue Rankings